Multiple sclerosis spasticity daily management: Retrospective data from Europe

Expert Review of Neurotherapeutics

Volumn 13, Issue 3 SUPPL. 1, 2013, Pages 3-7

  Berger, Thomas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

disease burden; epidemiology; multiple sclerosis; spasticity; treatment

Indexed keywords

CAREGIVER SUPPORT; CONFERENCE PAPER; DAILY LIFE ACTIVITY; GERMANY; HEALTH CARE COST; HUMAN; MULTIPLE SCLEROSIS; MUSCLE SPASM; PATIENT CARE; PATIENT SATISFACTION; QUALITY OF LIFE; REHABILITATION CARE; RETROSPECTIVE STUDY; SPAIN; SPASTICITY; URINARY DYSFUNCTION; URINARY URGENCY;

ANTI-DYSKINESIA AGENTS; CANNABINOID RECEPTOR AGONISTS; COST OF ILLNESS; EUROPE; EXCITATORY AMINO ACID ANTAGONISTS; HEALTH CARE COSTS; HUMANS; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84873337045     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.3     Document Type: Conference Paper

References (9)

1. Barnes MP, Kent RM, Semlyen JK, McMullen KM. Spasticity in multiple sclerosis. Neurorehabil. Neural Repair 17, 66-70 (2003). (Pubitemid 37102029)
2. Stevenson VL. Rehabilitation in practice: spasticity management. Clin. Rehab. 24, 293-304 (2010).
3. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult. Scler. 10, 589-595 (2004). (Pubitemid 39207235)
4. Oreja-Guevara C. Clinical efficacy and effectiveness of Sativex®, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. Expert Rev. Neurother. 12(Suppl. 4), 3-8 (2012).
5. Arroyo R, Vila C, Clissold S. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: The '5E' study. Expert Rev. Pharmacoecon. Outcomes Res. 11, 205-213 (2011).
6. Flachenecker P, Henze T, Hengsbach M, Ehlken B, Zettl UK. Spasticity in multiple sclerosis - a cross-sectional survey in Germany. Mult. Scler. 18, S21 (2012).
7. Kobelt G, Lindgren P, Smala A; the German MS Study Group. Costs and quality of life in multiple sclerosis. A cross-sectional observational study in Germany. Eur. J. Health Econ. 2, 60-68 (2001). (Pubitemid 33014731)
8. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 5, 378-385 (1999). (Pubitemid 30003764)
9. Groen H, van der Bij W, Koëter GH, TenVergert EM. Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am. J. Transplantation 4, 1155-1162 (2004). (Pubitemid 38868608)